Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%
Key Points:
- Users clicking the "Proceed" button on Barron's website will be redirected to a third-party site operated by Hong Kong Tiimoot Information Technology Co., Limited (HKT).
- The redirected website is independent of Barron's and is located in Hong Kong.
- Barron's does not control the third-party website or its content.
- Users are advised to review HKT's Privacy Statement, as Barron's is not responsible for HKT's privacy or data practices.